The effect of age on the tolerability of intraperitoneal chemotherapy, complication rate, and survival in patients with ovarian cancer

Gynecologic Oncology

Volumn 119, Issue 3, 2010, Pages 491-495

  Kothari, Rajul ^a   Nagel, Christa ^b   Koopmeiners, Joseph S ^a   Ivy, Joseph J ^a   Geller, Melissa ^a   Salani, Ritu ^b   Argenta, Peter A ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

Author keywords

Complications; Elderly; Intraperitoneal chemotherapy; Ovarian cancer; Survival

Indexed keywords

CARBOPLATIN; CISPLATIN; DOCETAXEL; PACLITAXEL;

ABDOMINAL PAIN; ADULT; AGE; AGED; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CANCER SURVIVAL; COHORT ANALYSIS; CONTROLLED STUDY; DRUG SUBSTITUTION; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; MULTIPLE CYCLE TREATMENT; NAUSEA; NEUROPATHY; NEUTROPENIA; OTOTOXICITY; OUTCOME ASSESSMENT; OVARY CANCER; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; STATISTICAL SIGNIFICANCE; THROMBOCYTOPENIA; TREATMENT PLANNING; VAGINA DISEASE;

AGE FACTORS; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CISPLATIN; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; INFUSIONS, INTRAVENOUS; INFUSIONS, PARENTERAL; NEOPLASM STAGING; OVARIAN NEOPLASMS; PACLITAXEL; RETROSPECTIVE STUDIES; TAXOIDS;

EID: 78149359264     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.08.026     Document Type: Article

References (18)

1. D.K. Armstrong, B. Bundy, L. Wenzel, H.Q. Huang, R. Baergen, and S. Lele Intraperitoneal cisplatin and paclitaxel in ovarian cancer N Engl J Med 354 1 Jan 5 2006 34 43
2. C. Marth, J.L. Walker, R.R. Barakat, A. Casado, A. Gadducci, and B. Miller Results of the 2006 Innsbruck International Consensus Conference on intraperitoneal chemotherapy in patients with ovarian cancer Cancer 109 4 Feb 15 2007 645 649
3. M. Markman, B.N. Bundy, D.S. Alberts, J.M. Fowler, D.L. Clark-Pearson, and L.F. Carson Phase III trial of standard-dose intravenous cisplatin plus paclitaxel versus moderately high-dose carboplatin followed by intravenous paclitaxel and intraperitoneal cisplatin in small-volume stage III ovarian carcinoma: an intergroup study of the Gynecologic Oncology Group, Southwestern Oncology Group, and Eastern Cooperative Oncology Group J Clin Oncol 19 4 Feb 15 2001 1001 1007
4. http://seer.cancer.gov/csr/1975-2007/results-single/sect-01-table. 10-2pgs.pdf (Accessed on 5-5-2010).
5. J.H. Lewis, M.L. Kilgore, D.P. Goldman, E.L. Trimble, R. Kaplan, and M.J. Montello Participation of patients 65 years of age or older in cancer clinical trials J Clin Oncol 21 2003 1383 1389
6. C.K. Lee, M. Pires de Miranda, J.A. Ledermann, M.C. Ruiz de Elvira, A.E. Nelstrop, and H.E. Lambert Outcome of epithelial ovarian cancer in women under 40 years of age treated with platinum-based chemotherapy Eur J Cancer 35 5 May 1999 727 732
7. P. Wimberger, N. Lehmann, R. Kimmig, A. Burges, W. Meier, and B. Hoppenau Impact of age on outcome in patients with advanced ovarian cancer treated within a prospectively randomized phase III study of the Arbeitsgemeinschaft Gynaekologische Onkologie Ovarian Cancer Study Group (AGO-OVAR) Gynecol Oncol 100 2 Feb 2006 300 307
8. W.E. Winter III, G.L. Maxwell, C. Tian, J.W. Carlson, R.F. Ozols, and P.G. Rose Prognostic factors for stage III epithelial ovarian cancer: a Gynecologic Oncology Group Study J Clin Oncol 25 24 Aug 20 2007 3621 3627
9. Fast Stats: An interactive tool for access to SEER cancer statistics. Surveillance Research Program, National Cancer Institute. http://seer.cancer. gov/faststats. (Accessed on 5-5-2010).
10. M. Markman, J.L. Lewis Jr., P. Saigo, T. Hakes, W. Jones, and S. Rubin Epithelial ovarian cancer in the elderly. The Memorial Sloan-Kettering Cancer Center experience Cancer 71 2 Suppl Jan 15 1993 634 637
11. R.D. Hightower, H.N. Nguyen, H.E. Averette, W. Hoskins, T. Harrison, and A. Steren National survey of ovarian carcinoma: IV. Patterns of care and related survival for older patients Cancer 73 2 Jan 15 1994 377 383
12. E.H. Duthie Jr., K.P., and M.L. Malone Practice of geriatrics 4th ed. 2007 Saunders Elsevier Philadelphia
13. L.F. Hutchins, J.M. Unger, J.J. Crowley, C.A. Coltman Jr., and K.S. Albain Underrepresentation of patients 65 years of age or older in cancer-treatment trials N Engl J Med 341 27 Dec 30 1999 2061 2067
14. L.L.G. Balducci, and W.B. Ershler Comprehensive geriatric oncology 1998 Harwood Academic Publishers Amsterdam, the Netherlands
15. M.A. Bookman, M.F. Brady, W.P. McGuire, P.G. Harper, D.S. Alberts, and M. Friedlander Evaluation of new platinum-based treatment regimens in advanced-stage ovarian cancer: a Phase III Trial of the Gynecologic Cancer Intergroup J Clin Oncol 27 9 2009 1419 1425
16. R. Yancik, M.N. Wesley, L.A. Ries, R.J. Havlik, S. Long, and B.K. Edwards Comorbidity and age as predictors of risk for early mortality of male and female colon carcinoma patients: a population-based study Cancer 82 11 Jun 1 1998 2123 2134
17. D.B. Reuben, L.V. Rubenstein, S.H. Hirsch, and R.D. Hays Value of functional status as a predictor of mortality: results of a prospective study Am J Med 93 6 Dec 1992 663 669
18. E.L. Eisenhauer, W.P. Tew, D.A. Levine, S.M. Lichtman, C.L. Brown, and C. Aghajanian Response and outcomes in elderly patients with stages IIIC-IV ovarian cancer receiving platinum-taxane chemotherapy Gynecol Oncol 106 2 Aug 2007 381 387